Fig. 3From: Computational analysis of receptor tyrosine kinase inhibitors and cancer metabolism: implications for treatment and discovery of potential therapeutic signaturesThe metabolic signature of RTK inhibitors on cancer cell lines and the corresponding network visualization of relationships between signature components and metabolic pathways. a: breast cancer; b: CNSBack to article page